Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Sci Rep ; 7: 41824, 2017 02 02.
Article in English | MEDLINE | ID: mdl-28150739

ABSTRACT

Rett syndrome (RTT) is a neurodevelopmental disease that leads to intellectual deficit, motor disability, epilepsy and increased risk of sudden death. Although in up to 95% of cases this disease is caused by de novo loss-of-function mutations in the X-linked methyl-CpG binding protein 2 gene, it is a multisystem disease associated also with mitochondrial metabolic imbalance. In addition, the presence of long QT intervals (LQT) on the patients' electrocardiograms has been associated with the development of ventricular tachyarrhythmias and sudden death. In the attempt to shed light on the mechanism underlying heart failure in RTT, we investigated the contribution of the carnitine cycle to the onset of mitochondrial dysfunction in the cardiac tissues of two subgroups of RTT mice, namely Mecp2+/- NQTc and Mecp2+/- LQTc mice, that have a normal and an LQT interval, respectively. We found that carnitine palmitoyltransferase 1 A/B and carnitine acylcarnitine translocase were significantly upregulated at mRNA and protein level in the heart of Mecp2+/- mice. Moreover, the carnitine system was imbalanced in Mecp2+/- LQTc mice due to decreased carnitine acylcarnitine transferase expression. By causing accumulation of intramitochondrial acylcarnitines, this imbalance exacerbated incomplete fatty acid oxidation, which, in turn, could contribute to mitochondrial overload and sudden death.


Subject(s)
Carnitine/metabolism , Metabolic Networks and Pathways/genetics , Rett Syndrome/genetics , Rett Syndrome/metabolism , Acetyl Coenzyme A/metabolism , Animals , Carnitine/analogs & derivatives , Disease Models, Animal , Electrocardiography , Female , Genes, X-Linked , Lipid Metabolism , Metabolomics/methods , Methyl-CpG-Binding Protein 2/genetics , Mice , Mice, Knockout , Mitochondria/genetics , Mitochondria/metabolism , Mutation , Oxidation-Reduction , Phenotype , Pyruvate Dehydrogenase Complex/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rett Syndrome/diagnosis
2.
PLoS One ; 7(5): e37921, 2012.
Article in English | MEDLINE | ID: mdl-22655081

ABSTRACT

A novel acylpeptide hydrolase, named APEH-3(Ss), was isolated from the hypertermophilic archaeon Sulfolobus solfataricus. APEH is a member of the prolyl oligopeptidase family which catalyzes the removal of acetylated amino acid residues from the N terminus of oligopeptides. The purified enzyme shows a homotrimeric structure, unique among the associate partners of the APEH cluster and, in contrast to the archaeal APEHs which show both exo/endo peptidase activities, it appears to be a "true" aminopeptidase as exemplified by its mammalian counterparts, with which it shares a similar substrate specificity. Furthermore, a comparative study on the regulation of apeh gene expression, revealed a significant but divergent alteration in the expression pattern of apeh-3(Ss) and apeh(Ss) (the gene encoding the previously identified APEH(Ss) from S. solfataricus), which is induced in response to various stressful growth conditions. Hence, both APEH enzymes can be defined as stress-regulated proteins which play a complementary role in enabling the survival of S. solfataricus cells under different conditions. These results provide new structural and functional insights into S. solfataricus APEH, offering a possible explanation for the multiplicity of this enzyme in Archaea.


Subject(s)
Peptide Hydrolases/chemistry , Peptide Hydrolases/metabolism , Sulfolobus solfataricus/enzymology , Amino Acid Sequence , Gene Expression Regulation, Archaeal , Hot Temperature , Molecular Sequence Data , Oxidative Stress , Peptide Hydrolases/genetics , Phylogeny , Protein Structure, Secondary , Substrate Specificity , Sulfolobus solfataricus/chemistry , Sulfolobus solfataricus/genetics
SELECTION OF CITATIONS
SEARCH DETAIL